About KLOXXADO®

Naloxone hydrochloride, the active ingredient in KLOXXADO®, is an opioid antagonist that quickly works to reverse the effects of an opioid overdose. Naloxone is safe to use even if opioids aren’t present.

KLOXXADO® is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients. KLOXXADO® is not a substitute for emergency medical care. KLOXXADO® is intended for immediate administration as emergency therapy in settings where opioids may be present.

Media Contacts

If you’re a journalist researching KLOXXADO®, opioid overdose, fentanyl or naloxone in your community, please email us for a comment or more information.

Images & Assets for Media Use

THUMB Kloxxado Inhaler Left

KLOXXADO® Device (left-facing)

THUMB Kloxxado Inhaler Right

KLOXXADO® Device (right-facing)

US FDA Approves KLOXXADO® (naloxone HCl) Nasal Spray 8 mg to Treat Opioid Overdose

On April 30, 2021, the US Food and Drug Administration approved of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, a new opioid overdose reversal medication.

Kloxxado Device